This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The number of machine learning- and AI-powered medicaldevices approved by the U.S. In 2024, the FDA approved nearly 1,000 AI medicaldevices compared to just 221 in 2023. At the same time, there are concerns about whether the FDA has approved some medicaldevices too quickly.
With strong demand for medical imaging in many differing clinical contexts, hospitals are managing growing routine imaging demands while balancing teaching practices, ambulatory services, primary care, and subspecialty services. billion healthcare facility. Another, a new hospital complex is underway at University of Utah Health.
French imaging software developer Median Technologies is highlighting results from the RELIVE clinical trial regarding its AI-based CADe/CADx software as a medicaldevice for lung cancer screening, eyonis LCS.
MD, issued a nine-page letter to Congress recommending how to solve the reimbursement problem for AI in healthcare and ensure clinical AI is of value to patients and health systems. American College of Radiology (ACR) CEO William Thorwarth Jr., As of May 6, the ACR estimated that there are approximately 250 U.S. William Thorwarth Jr.,
Researchers led by Seyed Tabatabaei, MD, from Massachusetts General Hospital and Harvard Medical School in Boston, in their clinical perspective outlined these pitfalls and made suggestions on AI model training and validation, as well as using diverse datasets.
Far from being expendable, human medical experts will remain the linchpin of our healthcare system and the indispensable source of truth whose inputs allow AI models to learn as they go in ways that improve patient health. Researchers are also pairing AI models with specific targeting compounds to help improve diagnostic accuracy.
In healthcare, algorithms hold the promise of increasing efficiency and, potentially, diagnostic accuracy. By investing in AI education, healthcare organizations can empower radiologists to streamline workflows, enhance diagnostic accuracy, and deliver personalized care. Morris Panner, President of Intelerad. The examples are many.
milla1cf Fri, 09/08/2023 - 16:25 September 8, 2023 — Positron Corporation , a leading molecular imaging medicaldevice company, is pleased to announce that the Company will begin its clinical study of its Affinity PET-CT imaging device with Ochsner Clinic Foundation in New Orleans, LA. on September 18, 2023.
The right to repair medicaldevices movement is gaining momentum, with all 50 states in the U.S. If enacted, this right to repair for medicaldevices legislation would take effect July 1. now addressing the issue through legislation.
10, 2025 Ibex Medical Analytics recentlyannouncedit has received U.S. Amin, MD, Vice President and Medical Director of Labcorps Hospital Systems Operating Division and Clinical Professor of Pathology and Laboratory Medicine at the University of Tennessee Health Science Center. tim.hodson Mon, 02/10/2025 - 11:56 Feb.
mtaschetta-millane Wed, 07/17/2024 - 10:52 July 17, 2024 — Hyperfine , a groundbreaking medicaldevice company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop system—announced the clearance of the ninth generation of AI-powered Swoop system software.
The MR 5300 with BlueSeal technology is designed to provide helium-free MR imaging capabilities in a mobile format, increasing access to care with advanced medicaldiagnostics for communities in both rural and urban areas. Nebraska Medicine will be the first to bring the Mobile MR 5300 into its clinical operations.
Positron joins forces with the coalitions founding members, Bracco Diagnostics , CDL Nuclear Technologies and Siemens Healthcare who have come together to promote federal policies that advance health outcomes for patients with cardiovascular disease and improve the availability of cardiac PET diagnostics throughout the United States.
milla1cf Fri, 01/26/2024 - 21:11 January 26, 2024 — InkSpace Imaging , a leader in innovative diagnosticmedicaldevice technology, is proud to announce it received FDA clearance for its next-generation Small Body Array for the Siemens Healthineers Magnetom Skyra and Vida series 3T MRI scanners.
Positron’s new Attrius customer will take advantage of the Company’s Lease to Own Program which provides a complete package of an Attrius PET System and the full scope Clinical & Technical Services for one monthly price. The Attrius PET is a tremendous tool for advanced cardiac studies and diagnostics.
Advanced Image Processing Algorithm: The OmniTom Elite now supports post-reconstruction features such as Virtual Non-Contrast (VNC) and bone removal, enhancing diagnostic capabilities and image quality. We will continue to develop leading technologies to improve medical staff's convenience and diagnostic accuracy.
Advanced Image Processing Algorithm: The OmniTom Elite now supports post-reconstruction features such as Virtual Non-Contrast (VNC) and bone removal, enhancing diagnostic capabilities and image quality. We will continue to develop leading technologies to improve medical staff's convenience and diagnostic accuracy.
mtaschetta-millane Thu, 07/25/2024 - 08:28 July 25, 2024 — Positron Corporation , a leading molecular imaging medicaldevice company offering PET & PET-CT imaging systems, presents its new NeuSight PET-CT 3D 64 slice scanner, available for US and North American Markets.
The companies are partnering to further enable the Polarean xenon 129 MRI platform to accelerate clinical and research use. These new products and services will be utilised to expand access to xenon 129 MRI as a lung imaging service and to investigate new indications and biomarkers in broader populations with unmet medical needs.
Interventional radiologists received an aggregate of over $60 million in payments from drug and medicaldevice companies between 2017 and 2021, but most of this money is going to just a few of these physicians, according to research published July 24 in Current Problems in Diagnostic Radiology.
milla1cf Fri, 03/15/2024 - 16:41 March 15, 2024 — Visitors to the Philips Booth at HIMSS in Orlando, Fla, experienced smart, scalable and sustainable clinical solutions designed to help accelerate speed to diagnosis and treatment while improving operational efficiencies, patient outcomes, health equity, and staff experience.
Compared to conventional scanners, the O-scan has a compact footprint that can fit into almost any clinical setting and a comfortable, open-concept design that is ideal for scanning children and claustrophobic patients," says Stephen Gibbs , Marketing and Sales Manager at Esaote North America, Inc.
milla1cf Thu, 03/07/2024 - 20:10 March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence ( AI )-enabled medicaldevices and digital solutions in Booth 2500 at the Health Information and Management Systems Society ( HIMSS ) Global Health Conference and Exhibition in Orlando, FL from March 11-15, 2024.
This advancement promises to transform the landscape of intraoperative diagnostics, offering real-time insights that can make all the difference in patient care. The operating room faces enormous challenges in terms of patient volume and complexity.
NeuroShield is currently in clinical use in over 220+ sites across the world. In-Med is supported by seed funding from Sriram Natarajan, Founder & CEO of Molbio Diagnostics. Role of Volumetric Analysis in Correlation of Gender and Atrophy in Dementia in Clinical Practice. References: [i] JOSHI, J. Kulkarni, A.
Reading Time: 9 minutes read Mid-cycle refresh can increase clinical, operational, and security benefits. Does it support new medical imaging software that can help improve clinical outcomes? Physicians have better diagnostic confidence when they can view radiographs in the manner most suitable to their preferences.
The UW Clinical Tumor Ablation Program draws patients from all over the world to Madison. He is an inventor of two of the world’s most widely applied tumor ablation devices, which have been used to cure, prolong life, or relieve symptoms in over 80,000 cancer patients. Meet the 2023 Dr.
10, 2025 Ibex Medical Analytics recentlyannouncedit has received U.S. Amin, MD, Vice President and Medical Director of Labcorps Hospital Systems Operating Division and Clinical Professor of Pathology and Laboratory Medicine at the University of Tennessee Health Science Center. tim.hodson Mon, 02/10/2025 - 11:56 Feb.
today announced a collaboration to bring together their complementary expertise, capabilities and technology to build and implement AI-enabled diagnostic products. to develop, productize and deploy diagnostic-focused AI solutions to address pain points in medical imaging. 26 – 30 in Chicago, IL. Annalise.ai
Annalise Enterprise CTB is now CE marked as class IIb under EU MedicalDevice Regulation (EU MDR) and additionally has been approved for clinical use in Singapore. It has been shown to improve diagnostic accuracy by 32%, averaged across all analyzed findings.
Beginning as point solutions intended to solve singular hospital pain points, clinical AI has since widened its scope and is making a crater-sized impact throughout the healthcare enterprise. Yet with a growing body of clinical validation , there is still no single entity holding full control of AI oversight.
Beginning as point solutions intended to solve singular hospital pain points, clinical AI has since widened its scope and is making a crater-sized impact throughout the healthcare enterprise. Yet with a growing body of clinical validation , there is still no single entity holding full control of AI oversight.
Beginning as point solutions intended to solve singular hospital pain points, clinical AI has since widened its scope and is making a crater-sized impact throughout the healthcare enterprise. Yet with a growing body of clinical validation , there is still no single entity holding full control of AI oversight.
However, adoption varies across specialties: Interventional radiologists have embraced AI faster, leveraging their strong ties to radiology, where many clinical AI solutions originated. AI tools that drive clinical efficiency without disrupting workflows.
This digital pathology solution is an excellent and important addition to the growing portfolio of collaborative radiology, medicaldevice and other solutions that harness the PowerShare network’s ubiquity, reliability and security to support the earlier detection and treatment of disease and empower physicians to deliver high-quality care.”
The solution was designed to seamlessly support the art of precision cancer diagnostics for pathologists. The software uses whole slide images from multiple scanning vendors to create a comprehensive solution for digital pathology across laboratories.
Over 700 devices are categorized as “artificial intelligence and machine learning enabled medicaldevices” on the FDA website. Healthcare AI vs. Clinical AI The terms “healthcare AI” and “clinical AI” might seem interchangeable, but there’s a key distinction.
Breast imaging is another area where AI is gaining ground , with AI algorithms used for both diagnostic support and workflow optimization. One of the key exhibitors to look out for is Aidoc (Booth #4911), a pioneer in clinical AI. These systems are helping streamline treatment, saving valuable time during critical moments.
This year saw AIs heightened presence at major healthcare conferences, a surge in clinical evidence validating its use and an ever-expanding list of FDA-cleared AI-enabled medicaldevices. AI is changing that, which can explain its rise to ascension in clinical spaces. In clinical applications, AI showed tangible impact.
However, the focus for these vendors also, and primarily will be on the clinical opportunity. Although generative AI diagnostic tools cannot be used in a clinical setting yet due to regulation, vendors have begun exploring the ability to leverage foundation models to streamline product development.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content